Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer.
Bewick
Mary A
MA
Conlon
Michael S C
MS
Lafrenie
Robert M
RM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000235:genetics* / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D004268:DNA-Binding Proteins / Q000235:genetics*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D005260:Female; D006239:Haplotypes; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D033581:Stem Cell Transplantation; D016896:Treatment Outcome; D000076105:X-ray Repair Cross Complementing Protein 1
D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human